Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity.
Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity.
The aim of this study was to assess the ability of currently deployed antimalarials to inhibit mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase (SERCA). Artemisinins exert their antiplasmodial action by inhibiting parasite PfATP6, a SERCA enzyme, and possess neurotoxic potential; mefloquine is neurotoxic and inhibits mammalian SERCA, an orthologue of PfATP6. SERCA in rabbit muscle was tested in vitro for inhibition by artemisinin and amino alcohol antimalarials. Significant inhibition of mammalian SERCA, as mean difference from uninhibited, control values was seen with both enantiomers of mefloquine: (+)-mefloquine (10 microM: -35.83, 95% CI -59.63 to -12.03; 50 microM: -54.06, 95% CI -77.86 to -30.26); (-)-mefloquine (10 microM: -24.35, 95% CI -41.56 to -7.15; 50 microM: -58.42, 95% CI -75.62 to -41.22); lumefantrine (1 microM: -25.46, 95% CI -45.82 to -5.10; 5 microM -34.83, 95% CI -60.08 to -9.58; 10 microM: -25.80, 95% CI -51.05 to -0.55); desbutyl-lumefantrine (5 microM: -50.16, 95% CI -84.24 to -16.08); dihydroartemisinin (1 microM: -39.25, 95% CI -63.74 to -14.76; 5 microM: -39.30, 95% CI -64.88 to -13.72). Dihydroartemisinin in higher concentrations (10 microM) stimulated SERCA activity: (+40.90, 95% CI 11.37 to 70.44). No statistically significant inhibition was seen with artemether at 1, 5 and 10 microM. Equimolar combinations of artemether and lumefantrine or of dihydroartemisinin and lumefantrine, when studied at concentrations that inhibit SERCA individually, failed to show any inhibition. Dihydroartemisinin, mefloquine, lumefantrine and desbutyl lumefantrine inhibit mammalian SERCA at periphysiological concentrations, although the neurotoxicity of mefloquine is not wholly attributable to this property. Candidate antimalarials should be screened pre-clinically for SERCA inhibition.
209-213
Toovey, Stephen
6b91c0bd-91e8-4569-a31c-d1e40c042710
Bustamante, Leyla Y.
cc9c7c2e-b2bb-409c-8f04-d3e770289f89
Uhlemann, Anne-Catrin
632746d3-594d-419b-9e6d-810f60ae1e00
East, J. Malcolm
9fe7f794-1d89-4935-9a99-b831d786056e
Krishna, Sanjeev
5e876d22-5ad7-482d-8ae0-3efa0295d3cf
September 2008
Toovey, Stephen
6b91c0bd-91e8-4569-a31c-d1e40c042710
Bustamante, Leyla Y.
cc9c7c2e-b2bb-409c-8f04-d3e770289f89
Uhlemann, Anne-Catrin
632746d3-594d-419b-9e6d-810f60ae1e00
East, J. Malcolm
9fe7f794-1d89-4935-9a99-b831d786056e
Krishna, Sanjeev
5e876d22-5ad7-482d-8ae0-3efa0295d3cf
Toovey, Stephen, Bustamante, Leyla Y., Uhlemann, Anne-Catrin, East, J. Malcolm and Krishna, Sanjeev
(2008)
Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity.
Basic & Clinical Pharmacology & Toxicology, 103 (3), .
(doi:10.1111/j.1742-7843.2008.00256.x).
Abstract
The aim of this study was to assess the ability of currently deployed antimalarials to inhibit mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase (SERCA). Artemisinins exert their antiplasmodial action by inhibiting parasite PfATP6, a SERCA enzyme, and possess neurotoxic potential; mefloquine is neurotoxic and inhibits mammalian SERCA, an orthologue of PfATP6. SERCA in rabbit muscle was tested in vitro for inhibition by artemisinin and amino alcohol antimalarials. Significant inhibition of mammalian SERCA, as mean difference from uninhibited, control values was seen with both enantiomers of mefloquine: (+)-mefloquine (10 microM: -35.83, 95% CI -59.63 to -12.03; 50 microM: -54.06, 95% CI -77.86 to -30.26); (-)-mefloquine (10 microM: -24.35, 95% CI -41.56 to -7.15; 50 microM: -58.42, 95% CI -75.62 to -41.22); lumefantrine (1 microM: -25.46, 95% CI -45.82 to -5.10; 5 microM -34.83, 95% CI -60.08 to -9.58; 10 microM: -25.80, 95% CI -51.05 to -0.55); desbutyl-lumefantrine (5 microM: -50.16, 95% CI -84.24 to -16.08); dihydroartemisinin (1 microM: -39.25, 95% CI -63.74 to -14.76; 5 microM: -39.30, 95% CI -64.88 to -13.72). Dihydroartemisinin in higher concentrations (10 microM) stimulated SERCA activity: (+40.90, 95% CI 11.37 to 70.44). No statistically significant inhibition was seen with artemether at 1, 5 and 10 microM. Equimolar combinations of artemether and lumefantrine or of dihydroartemisinin and lumefantrine, when studied at concentrations that inhibit SERCA individually, failed to show any inhibition. Dihydroartemisinin, mefloquine, lumefantrine and desbutyl lumefantrine inhibit mammalian SERCA at periphysiological concentrations, although the neurotoxicity of mefloquine is not wholly attributable to this property. Candidate antimalarials should be screened pre-clinically for SERCA inhibition.
Text
East_Toovey_et_al_2008.pdf
- Other
Restricted to Repository staff only
Request a copy
More information
e-pub ahead of print date: 18 July 2008
Published date: September 2008
Identifiers
Local EPrints ID: 141694
URI: http://eprints.soton.ac.uk/id/eprint/141694
ISSN: 1742-7835
PURE UUID: 3703ee5e-c28e-4963-bf77-bc260489688d
Catalogue record
Date deposited: 29 Mar 2010 15:25
Last modified: 14 Mar 2024 00:38
Export record
Altmetrics
Contributors
Author:
Stephen Toovey
Author:
Leyla Y. Bustamante
Author:
Anne-Catrin Uhlemann
Author:
Sanjeev Krishna
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics